APA

van Hartingsveldt B., Nnane I. P., Bouman-Thio E., Loza M. J., Piantone A., Davis H. M. & Petty K. J. (20131001). Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. : British journal of clinical pharmacology.

Chicago

van Hartingsveldt Bart, Nnane Ivo P, Bouman-Thio Esther, Loza Matthew J, Piantone Alexa, Davis Hugh M and Petty Kevin J. 20131001. Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. : British journal of clinical pharmacology.

Harvard

van Hartingsveldt B., Nnane I. P., Bouman-Thio E., Loza M. J., Piantone A., Davis H. M. and Petty K. J. (20131001). Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. : British journal of clinical pharmacology.

MLA

van Hartingsveldt Bart, Nnane Ivo P, Bouman-Thio Esther, Loza Matthew J, Piantone Alexa, Davis Hugh M and Petty Kevin J. Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. : British journal of clinical pharmacology. 20131001.